Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stroke and Coated-Platelets
NCT04698031Phase 4Active, not recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Mar 2022
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in Silent Brain Infarction (SBI), sponsored by VA Office of Research & Development. Started Mar 2022; status: active, not recruiting.
02
Drugs
clopidogrel
03
Conditions
Silent Brain Infarction (SBI)
Beyond the preview
Go deeper on NCT04698031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04698031.